(6) BNT162b2-Vaccine-Induced Neutralization Responses are Immune Correlates of Clinical Protection Against SARS-CoV-2 in Heart Transplant Recipients [PDF]
, 2023 Y. Peled +12 more
openalex +1 more source
Humoral Response to BNT162b2 and CoronaVac in Patients Undergoing Maintenance Hemodialysis: A Multicenter Prospective Cohort Study. [PDF]
, 2023 Alagoz S. +10 more
core +2 more sources
Anti-SARS-CoV-2 RBD IgG responses in convalescent versus naïve BNT162b2 vaccine recipients
, 2021 Lorenzo Azzi +4 more
openalex +2 more sources
Superior immunogenicity and effectiveness of the 3rd BNT162b2 vaccine dose [PDF]
, 2021 Yaniv Lustig +15 more
openalex +1 more source
Side effects to BNT162b2 can be severe.
European review for medical and pharmacological sciences, 2022 Finsterer, J., Scorza, F.A.
openaire +2 more sources
P413 Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b2 vaccines in the immunosuppressed (RESCUE) [PDF]
, 2022 Anna Tran +3 more
openalex +1 more source
Effectiveness of BNT162b2 XBB Vaccine Against XBB and JN.1 Sublineages
medRxivIn this Brief Report we provide updated results (October 11, 2023 through February 29, 2024) from our previously conducted test-negative case-control study in Kaiser Permanente Southern California to evaluate sub-lineage-specific effectiveness of the ...
S. Tartof +6 more
semanticscholar +1 more source
VaccinesThe SARS-CoV-2 Omicron variant and its sublineages continue to cause COVID-19-associated pediatric hospitalizations, severe disease, and death globally. BNT162b2 and CoronaVac are the main vaccines used in Chile.
Diego A. Díaz-Dinamarca +15 more
doaj +1 more source
Disparities in response to mRNA SARS-CoV-2 vaccines according to sex and age: A systematic review [PDF]
BACKGROUND The rapid development and distribution of mRNA COVID-19 vaccines has been essential in containing the SARS-CoV-2 epidemic around the globe.
Bachmann, Michelle +5 more
core +1 more source